Barrington Research Lowers Concentrix (NASDAQ:CNXC) Price Target to $30.00

Concentrix (NASDAQ:CNXC) had its price target dropped by investment analysts at Barrington Research from $38.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Barrington Research’s price target would suggest a potential upside of 45.29% from the company’s previous close.

Several other research firms also recently issued reports on CNXC. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a report on Monday, April 27th. Robert W. Baird decreased their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday. Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Canaccord Genuity Group set a $45.00 target price on Concentrix in a research report on Tuesday. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $35.00.

Concentrix Trading Down 18.2%

Concentrix stock traded down $4.58 during trading on Tuesday, hitting $20.65. The company had a trading volume of 2,656,678 shares, compared to its average volume of 1,629,117. Concentrix has a 1-year low of $19.12 and a 1-year high of $62.14. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.43. The company’s 50 day simple moving average is $25.84 and its 200-day simple moving average is $32.08. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -0.95, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the firm earned $2.70 EPS. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, analysts expect that Concentrix will post 10.42 EPS for the current fiscal year.

Insider Activity

In related news, CFO Andre S. Valentine purchased 2,500 shares of the business’s stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the acquisition, the chief financial officer directly owned 89,066 shares in the company, valued at $2,489,394.70. This trade represents a 2.89% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total value of $133,500,000.00. Following the completion of the sale, the insider directly owned 2,773,667 shares in the company, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Concentrix

Several hedge funds have recently added to or reduced their stakes in CNXC. Huntington National Bank grew its holdings in Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after acquiring an additional 541 shares in the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Concentrix by 224.9% during the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares during the last quarter. Allworth Financial LP lifted its position in shares of Concentrix by 90.6% during the 3rd quarter. Allworth Financial LP now owns 856 shares of the company’s stock worth $40,000 after purchasing an additional 407 shares during the last quarter. Finally, Global Retirement Partners LLC grew its stake in shares of Concentrix by 1,032.5% during the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after purchasing an additional 795 shares in the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Key Stories Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix declared a quarterly dividend of $0.36 per share, implying a 5.7% annualized yield, which may support income-focused investors.
• Positive Sentiment: Management highlighted record quarterly cash flow from operations and adjusted free cash flow, along with strong growth in iX Suite deals and an AI push that could help margins over time.
• Neutral Sentiment: Robert W. Baird lowered its price target on CNXC from $40 to $30 while keeping an outperform rating, signaling caution but still modest upside from current levels. Benzinga
• Neutral Sentiment: Analysts and media coverage note that the stock is reacting to the company’s revised guidance and earnings details, while the broader market tone was mixed to slightly positive in pre-market trading. Reuters article
• Negative Sentiment: CNXC missed second-quarter EPS and revenue estimates, with revenue of about $2.46 billion and EPS of $2.63 falling just short of expectations.
• Negative Sentiment: The company cut FY2026 and Q3 guidance below Wall Street estimates, citing softer client spending and margin pressure, which is the main reason the stock is trading lower today.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.